Greycoat Research and Dr. Arai Toshiro, a professor of feline veterinary medicine and an advisory expert for Greycoat Research, have begun conducting case studies on the antioxidant effect of resveratrol. Resveratrol is one of the main ingredients in Greycoat Research’s AIM Dr. Toru Protocol and Intensive Protocol supplements, which protect kidney functions and delay the progress of chronic kidney disease (CKD) in cats.
A total of 4 cats are participating in the case studies, and 3 will be administered with low, medium, and high doses of resveratrol respectively for a period of 4 weeks, while the remaining 1 will not receive any resveratrol to serve as the control group.
A paper announcing the results of the case studies is expected to be published in summer of 2025.
